Introduction The current study was undertaken to investigate the biomechanical and biologic in-growth characteristics of the Porous Coated Motion™ cervical disc prosthesis following a six and twelve-month implant duration using an in-vivo caprine model. Methods Twelve mature Nubian goats were divided into two groups based on post-operative survival periods of six (n=6) and twelve months (n=6). Using an anterior surgical approach, a complete diskectomy was performed at the C3-C4, followed by implantation of the Porous Coated Motion™ device. Functional outcomes of the disc prosthesis were based on computed tomography (CT), multi-directional flexibility testing, undecalcifed histology, histomorphometry and immunocytochemical analyses. Results There was no evidence of prosthesis loosening, neurologic or vascular complications. CT scans demonstrated the ability to image and assess the cervical spinal canal for the presence of compressive pathology in the area of the CoCrMo prosthesis. Multi-directional flexibility testing indicated no differences in full range of intervertebral motion between the disc prosthesis and non-operative controls (n=7) under axial rotation or lateral bending conditions (p> 0.05). Flexion-extension produced significantly more motion for the intact spine compared to the cervical disc prosthesis (p< 0.05). Based on immunohistochemical and histologic analysis, there was no evidence of particulate debris, cytokines or cellular apoptosis within the local tissues overlying the operative site or systemic tissues. Moreover, review of the spinal cord at the operative levels indicated no evidence of cord lesions, inflammatory reaction, wear particles or significant pathologic changes in any treatment. Histomorphometric analysis at the metal-bone interface indicated the mean trabecular ingrowth of 40.5±24.4% at six-months and 58.65% ± 28.04 at twelve months. Discussion All twelve goats undergoing cervical disc replacement had no evidence of implant loosening or inflammatory reactions from particulate wear debris. Segmental intervertebral motion was preserved based on multi-directional flexibility testing. The TiCaP porous ingrowth surface provided some immediate advantages for endplate osseointegration as there was no evidence of implant subluxation, despite immediate post-operative unrestricted cervical activity. Following cervical disc replacement, histological osseointegration at the implant-bone interface is possible, while preserving segmental motion

Aim. To study the efficacy of Hydroxyapatite (HAC) Ceramic Coated hip arthroplasty. Is it suitable for the younger patient?. Methods. This series of 2390 primary HAC hip arthroplasties has been studied for up to 21 years. (569 hips over 10 years including 98 hips over 15 years) Patients are assessed by Harris Hip Score and plain X-ray. The prosthesis consists of a fully coated stem and a fully coated acetabulum. A ceramic head articulates with an acetabular liner which is either plastic (UHMW polythene) or ceramic. No cement is used. HA coated implants are physiologically fixed to cancellous bone by a process of osseointegration. Other uncemented implants are pathologically fixed by fibrous scar tissue. These two methods of fixation should be considered separately and not combined as ‘uncemented’. Results. Aseptic loosening in this series is 0.63 %. The revision rate in this series for all reasons is only 3.5%. Harris Hip Score (HHS) demonstrates excellent medium to long term results in 97% of cases (i.e. up to 20 years). Poor HHS results (36 cases: 1.51%) are mostly related to medical or other joint problems. HA fixation will outlast some of the components and wear in polythene acetabular liners can be a problem after 15 years. A sub-group of 629 hips using alumina ceramic/ ceramic bearings is successful but five components fractured (out of 1258 individual components). Wear debris from ceramic materials appears to be benign. Zirconia Toughened Alumina (ZTA) has been introduced to replace alumina and should obviate problems of ceramic implant fracture. An HA coated implant with ZTA bearings is suggested for the younger patient of either sex

Introduction Adjacent segment disease with radiculopathy and neurologic deficit adjacent to a non-mobile spinal segment is the ideal application for cervical arthroplasty. Not only are the stresses and loads increased but unfortunately the previously fused segment is further compromised by being fixed in a kyphotic position. Methods This is a prospective study of 40 PCM prostheses inserted in thirty patients with 50 adjacent segments previously fused or rendered immobile—ten cases were performed as bi-level implantations. The inclusion and exclusion criteria were otherwise identical to the normal FDA prospective IDE criteria with all patients presenting with radiculopathy and a corresponding neurologic deficit confirmed by an MRI compressive lesion. Results The mean preoperative cervical lordosis was 2.65 degrees (−32 to 25), mean postoperative lordosis 12.3 degrees (−17 to 30), and the mean improvement was 9.4 degrees of cervical lordosis (range (−15 to 23). EBL = 0 to 100 cc with no patients requiring blood transfusions, Length of surgery = mean 104 minutes (60 to 150) and the length of hospital stay = mean 1.17 days (0 to 3 days). The clinical follow-up was greater than 2 years. All patients were neurologically intact at follow up with a mean improvement of NDI = 50 % and mean improvement in VAS = 58.3 %.The range of flexion and extension motion at the level of the prosthesis was a mean of 8.9 degrees (range 4 to 20 degrees). Discussion Naturally, the adjacent segment application of a cervical disc replacement is a challenging clinical environment for cervical arthroplasty – by definition every case had prior surgery. Not only is the cervical spine position often compromised by being in excessive kyphosis, but seventeen of the 50 previously fused levels had prior cervical instrumentation. 5 patients had previous cervical cages, 2 had cage-plates, 5 patients had previous anterior cervical plates, one had a prior arthroplasty device with HO, and 4 patients had PMMA which required revision. Despite the complicated nature of the presenting pathology, the Porous Coated Motion Cervical prosthesis successfully restored some element of cervical lordosis, and restored stability to the cervical segments. An added potential bonus is the preserved 9.4 degrees of flexion – extension mobility. The PCM appeared to work well in these revision cases. This is the world’s largest study to date investigating prospectively the value of cervical arthroplasty in adjacent segment disease

Cementless stem designs in total hip arthroplasty differ in relation to geometry and area of fixation. We utilised radiostereometric analysis (RSA) to evaluate the 2-year migration of a novel, short, proximally coated femoral stem.

30 participants undergoing primary total hip replacement for any cause (rheumatoid or inflammatory arthritis, osteoarthritis) were prospectively recruited in this study. Osteoporotic patients and cases of suspected infection were excluded. All patients received a short blade stem, proximally coated with a reduced lateral shoulder and narrow triple taper geometry to minimise bone removal. RSA radiographs were performed post-operatively and at 6 weeks, 6 months, 1- and 2 years. The Harris Hip Score (HHS), Oxford Hip Score (OHS) and EQ-5D were collected at baseline and at 2 years post-operatively. The stability of implants and complications were captured during each follow-up visit.

A total of 14 female and 16 male patients were recruited with a mean age of 64.8 (range 47 to 75). At two years the mean subsidence of the stem was 0.34 mm (SD 0.62) and the total migration 0.74 mm (SD 0.60). The mean medial translation at two years was 0.059 (0.24) and the mean anterior translation 0.12 (0.59) respectively. Baseline PROM scores improved significantly at 2-years from pre-operatively (median and interquartile range): HHS from 33 (18.25) to 92 (19), EQ5D from 0.5 (0.35) to 0.94 (0.17), OHS from 21 (18.25) to 42 (4.25). P-value for all comparisons was <0.001. 2-year follow up data revealed no complications. There were no stem revisions in study participants and no heterotopic ossifications were identified on radiographs.

2-year migration results of a cementless, short blade, proximally coated tapered femoral stem using RSA, showed the stem exhibits a predictable migration pattern and achieves initial stability. This is highly likely to translate to mid and long-term stability, which needs to be corroborated by long-term outcome studies. Furthermore, participants demonstrated excellent clinical, patient reported and radiological outcomes after 2 years of follow up to support expansion in the use of this prosthesis.

Production of porous titanium bone implants is a highly promising research and application area due to providing high osseointegration and achieving the desired mechanical properties. Production of controlled porosity in titanium implants is possible with laser powder bed fusion (L- PBF) technology. The main topics of this presentation includes the L-PBF process parameter optimization to manufacture thin walls of porous titanium structures with almost full density and good mechanical properties as well as good dimensional accuracy. Moreover, the cleaning and coating process of these structures to further increase osseointegration and then in-vitro biocompatibility will be covered.

The aim of this prospective randomised study was to compare the clinical and radiological results of a cemented all-polyethylene Ultima acetabular component with those of a cementless porous-coated acetabular component (PFC) following total hip replacement (THR). A total of 287 patients received either a polyethylene acetabular component (group A) or a cobalt–chromium porous-coated component (group B) with an identical cemented femoral component and 28 mm cobalt-chromium head, thus making it the largest study of its type. Patients were evaluated radiologically and clinically using the Harris hip score (HHS). Group A comprised 183 patients (73 male, 110 female) with a mean age of 71.3 years (55 to 89). Group B comprised 104 patients (48 male, 56 female) with a mean age of 69.8 years (56 to 89). A total of 16 patients (13 in Group A, three in Group B) did not have post-operative data for analysis. The mean follow-up in group A was 7.52 years (0.4 to 15.0) and in Group B 7.87 years (0.5 to 14.0).

At final follow-up the mean HHS was similar between groups A and B (74.5 (25 to 100) and 78.0 (37 to 100), respectively; p = 0.068). The total number of revisions for any cause was 28, 17 of which were in group A and 11 in group B. The ten-year survivorship was 86.8% (95% confidence interval (CI) 78.4 to 92.1) and 89.2% (95% CI 78.3 to 94.8) for groups A and B, respectively (log-rank p-value = 0.938). A total of 20 cemented and two cementless acetabular components had evidence of acetabular radiolucencies or acetabular component migration at last follow-up (p = 0.001).

These results indicate that patients with a cemented all-polyethylene and cementless porous-coated polyethylene lined acetabular component have similar long-term clinical outcomes.

Introduction

Long term data on the survivorship of cemented total knee arthroplasty (TKA) has demonstrated excellent outcomes; however, with younger, more active patients, surgeons have a renewed interest in improved biologic fixation obtained from highly porous, cementless implants. Early designs of cementless total knees systems were fraught with high rates of failure for aseptic loosening, particularly on the tibial component. Prior studies have assessed the bone ingrowth extent for tibial tray designs reporting near 30% extent of bone ingrowth ^(1,2). While these analyses were performed on implants that demonstrated unacceptably high rates of clinical failure, a paucity of data exists on the extent on bone ingrowth in contemporary implant designs with newer methods for manufacturing the porous surfaces. We sought to evaluate the extent of attached bone on retrieved cementless tibial trays to determine if patient demographics, device factors, or radiographic results correlate to the extent of bone ingrowth in these contemporary designs.

There has been a significant increase in the demand of polymeric scaffolds with promising affects in bone regeneration. However, inflammation is still a problem in transplantations to overcome with local antibiotic therapy. In this study, it is aimed to develop a functional POSS nanocage reinforced chitosan scaffold (CS/POSS) coated with drug loaded chitosan composite nanospheres to provide a controlled antibianyiotic delivery at the defect site. Gentamicin and vancomycin were selected as model antibiotic drugs. Drug loaded nanospheres were fabricated with electrospray method and characterized in terms of morphology, hydrodynamic size, surface charge, FT-IR, in vitro drug release, antimicrobial activity and cytotoxicity. CS/POSS scaffolds were fabricated via lyophilisation and characterized with mechanic, swelling test, SEM and micro CT analyses. Positively charged nanospheres with uniform morphology were obtained. High drug encapsulation efficiency (80–95%) and sustained release profile up to 25 days were achieved with a cumulative release of 80–90%. In addition, the release media of the nanospheres (in 6 hours, 24 hours and 25 days of incubation period) showed a strong antimicrobial activity against S.aureus and E.coli, and did not show any cytotoxic effect to 3T3 and SaOS-2 cell lines. CS/POSS scaffolds were obtained with high porosity (89%) and 223.3±55.2μm average pore size. POSS reinforcement increased the compression modulus from 755.7 to 846.1Pa for 10 % POSS addition. In vitro studies of nanosphere coated bilayer scaffolds have showed high cell viability. Besides ALP activity results showed that POSS incorporation significantly increased the ALP activity of Saos-2 cells cultured on the scaffold. In conclusion, these composites can be considered as a potential candidate in view of its enhanced physico-chemical properties as well as biological activities for infection preventive bone tissue engineering applications.

The technique for removal of bone ingrown extensively coated devices involves cutting the stem below the metaphyseal portion of the stem, followed by removal of the proximal stem and trephine removal of the cylindrical distal portion of the stem. This can be done with or without an extended trochanteric osteotomy (ETO). When the proximal portion of the stem is not bone ingrown (extensive proximal osteolysis, or the stem is broken) or the metaphyseal bone is easily accessed (there is no collar) the stem can be cut through a bone window. In all other cases an ETO at the level where the stem becomes a cylinder is required to disrupt the metaphyseal bone prosthesis interface, cut the stem and extract the proximal portion of the stem.

Glassman described the techniques for removal of cementless stems in 1992. Forty-two loose stems were easily removed, 11 fibrous stable implants were removed with thin osteotomes, and 11 bone ingrown, canal filling, extensively coated stems were removed with trephines. In no cases was reconstruction precluded by stem removal. The critical tools required included manufacturer specific removal tools, high speed burs, thin osteotomes, universal extraction device for connection to the neck, and multiple trephines.

More recently, Kancherla reported the use of trephines to remove 36 porous coated stems. Eighty-six percent of cases were bone ingrown after removal, however, complications included an extruded trephine causing a femoral fracture and two periprosthetic fractures thought to be secondary to trephine induced osteonecrosis. The authors recommend bypassing the most distally trephined bone by a minimum of 4 cm.

Trephines are very helpful for removing distally fixed stems. Multiple trephines need to be irrigated and changed frequently to avoid dull cutting teeth which can lead to bone necrosis.

Introduction

Cementless acetabular components are commonly used in primary and revision total hip arthroplasty, and most designs have been successful despite differences in the porous coating structure. Components with 2D titanium fiber mesh coating (FM) have demonstrated high survivorships up to 97% at 20 years¹. 3D tantalum porous coatings (TPC) have been introduced in an attempt to improve osseointegration and therefore implant fixation. Animal models showed good results with this new material one year after implantation², and clinical and radiographic studies have demonstrated satisfactory outcomes³. However, few retrieval studies exist evaluating in vivo bone ingrowth into TPC components in humans. We compared bone ingrowth between well-fixed FM and TPC retrieved acetabular shells using backscatter scanning electron microscopy (BSEM).

The technique for removal of bone ingrown extensively coated devices involves cutting the stem below the metaphyseal portion of the stem, followed by removal of the proximal stem and trephine removal of the cylindrical distal portion of the stem. This can be done with or without an extended trochanteric osteotomy (ETO). When the proximal portion of the stem is not bone ingrown (extensive proximal osteolysis, or the stem is broken) or the metaphyseal bone is easily accessed (there is no collar) the stem can be cut through a bone window. In all other cases an ETO at the level where the stem becomes a cylinder is required to disrupt the metaphyseal bone prosthesis interface, cut the stem and extract the proximal portion of the stem.

Glassman described the techniques for removal of cementless stems in 1992. 42 loose stems were easily removed, 11 fibrous stable implants were removed with thin osteotomes, and 11 bone ingrown, canal filling, extensively coated stems were removed with trephines. In no cases was reconstruction precluded by stem removal. The critical tools required included manufacturer specific removal tools, high speed burs, thin osteotomes, universal extraction device for connection to the neck, and multiple trephines.

More recently, Kancherla reported the use of trephines to remove 36 porous coated stems. 86% of cases were bone ingrown after removal, however, complications included an extruded trephine causing a femoral fracture and two periprosthetic fractures thought to be secondary to trephine induced osteonecrosis. The authors recommend bypassing the most distally trephined bone by a minimum of 4cm.

Trephines are very helpful for removing distally fixed stems. Multiple trephines need to be irrigated and changed frequently to avoid dull cutting teeth which can lead to bone necrosis.

Using an institutional database we have identified over 1000 femoral revisions using extensively porous-coated stems. Using femoral re-revision for any reason as an endpoint, the survivorship is 99 ± 0.8% (95% confidence interval) at 2 years, 97 ± 1.3% at 5 years, 95.6 ± 1.8% at 10 years, and 94.5 ± 2.2% at 15 years. Similar to Moreland and Paprosky, we have identified pre-revision bone stock as a factor affecting femoral fixation. When the cortical damage involved bone more than 10cm below the lesser trochanter, the survivorship, using femoral re-revision for any reason or definite radiographic loosening as an endpoint, was reduced significantly, as compared with femoral revisions with less cortical damage.

In addition to patients with Paprosky Type 3B and 4 femoral defects, there are rare patients with femoral canals smaller than 13.5mm or larger than 26mm that are not well suited to this technique. Eight and 10 inch stems 13.5 or smaller should be used with caution if there is no proximal bone support for fear of breaking. Patients with canals larger than 18mm may be better suited for a titanium tapered stem with flutes. While a monolithic stem is slightly more difficult for a surgeon to insert than a modular femoral stem there is little worry about taper junction failure.

Using an institutional database we have identified over 1000 femoral revisions using extensively porous-coated stems. Using femoral re-revision for any reason as an endpoint, the survivorship is 99 ± 0.8% (95% confidence interval) at 2 years, 97 ± 1.3% at 5 years, 95.6 ± 1.8% at 10 years, and 94.5 ± 2.2% at 15 years. Similar to Moreland and Paprosky, we have identified pre-revision bone stock as a factor affecting femoral fixation. When the cortical damage involved bone more than 10 cm below the lesser trochanter, the survivorship, using femoral re-revision for any reason or definite radiographic loosening as an endpoint, was reduced significantly, as compared with femoral revisions with less cortical damage.

In addition to patients with Paprosky type 3B and 4 femoral defects, there are rare patients with femoral canals smaller than 13.5 mm or larger than 26 mm that are not well suited to this technique. Eight and 10 inch stems 13.5 or smaller should be used with caution if there is no proximal bone support for fear of breaking. Patients with canals larger than 18 mm may be better suited for a titanium tapered stem with flutes. While a monolithic stem is slightly more difficult for a surgeon to insert than a modular femoral stem there is little worry about taper junction failure.

Abstract

The first porous-coated femoral component approved for use without cement was released in 1983. Today, there are many implants with a similar amount of porous coating. The hallmark of these porous-coated implants is a cylindrical shape distally and a triangular metaphyseal shape. Extensively coated components gain initial stability in the femoral diaphysis.

Since 1982, we have used extensively porous-coated femoral components in all our patients. Our oldest series of patients is a consecutive non-selected group of 211 hips that have been followed for a mean of 20 years. Combining the loose and the revised, there is only a 3% femoral failure. In addition, we have studied patients with disease processes not originally thought to work well with cementless techniques, including rheumatoid arthritis, avascular necrosis and patients over 65.

Despite the good results, the main concern is that proximal bone loss secondary to the stress shielding caused by a stiff extensively porous-coated femoral component will lead to difficulty at the time of revision. At a mean 14 years, we have not seen any adverse clinical consequences that can be attributed to proximal stress shielding, though the longer term consequences of adaptive femoral remodeling need to be followed. In our patients, extensive proximal bone loss secondary to stress shielding is a radiographic sign of bone ingrowth that occurs in 25% of cases. In the remaining 70–75% of cases, lesser degrees of proximal bone loss occur which confirm bone ingrowth.

Extensively coated components gain stability in the femoral diaphysis. The femoral diaphysis is prepared with straight reamers until the reamer engages the cortex for 5cm. A slightly larger straight femoral component is inserted with a scratch fit. No matter what the shape of the femur or how osteoporotic the patient, there will always be 4–5cm of cortical bone for fixation of a straight 6 inch stem.

Total hip arthroplasty (THA) is one of the most successful and commonly performed surgical interventions worldwide. Based on registry data, at one-year post THA, implant survivorship is nearly 100% and patient satisfaction is 90%. A novel, porous coated acetabular implant was introduced in Europe and Australia in 2007. Several years after its introduction, warnings were issued for the system when used with metal-on-metal bearings due to adverse local tissue reaction, with one study reporting a 24% failure rate (Dramis et al. 2014). A subsequent 2018 study by Teoh et al. showed that the acetabular system had a survival rate of 98.9% at five years when used with conventional polyethylene or ceramic bearing surfaces. The current study was conducted to determine the safety and effectiveness of the acetabular system using standard highly-crosslinked polyethylene (XLPE) and ceramic liners at five-year follow-up. Our hypothesis was that the acetabular system would exhibit survivorship comparable to other acetabular components on the market at five-year follow-up.

A prospective, non-randomized study was conducted from February 2009 to June 2017 at eight sites in Canada and the USA. One hundred fifty-five hips were enrolled and 148 hips analyzed after THA indicated for degenerative arthritis. At five-year follow-up, 103 subjects remained for final analysis. All patients received a zero, three, or multi-hole R3 acetabular shell with Stiktite porous coating (Smith & Nephew, Inc., Memphis, TN, USA). Standard THA surgical techniques were employed, with surgical approach and either of a XLPE or ceramic bearing surface chosen at the discretion of the surgeon. The primary outcome was revision at five-years post-op with secondary outcomes including the Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), radiographic analysis, and post-operative adverse events. Data and outcomes were analyzed using summary statistics with 95% confidence intervals, t-tests, and Wilcoxon Rank tests.

At five-year follow-up the overall success rate was 97.14% (95% CI: 91.88–100). When analyzed by liner type, the success rate was 96.81% (95% CI: 90.96–99.34) for polyethylene (n=94) and 100% (95% CI: 71.51–100) for ceramic (n=11), with no significant difference between either liner type (p=1). There were three revisions during the study (1.9%), two for femoral stem revision post fracture, and one for deep infection. The HHS (51.36 pre-op, 94.50 five-year), all 5 HOOS sub-scales, and WOMAC (40.9 pre-op, 89.13 five-year) scores all significantly improved (p < 0 .001) over baseline scores at all follow-up points. One (0.7%) subject met the criteria for radiographic failure at one-year post-op but did not require revision. Six (1.8%) of the reported adverse events were considered related to the study device, including four cases of squeaking, one bursitis, and one femur fracture.

Results from this five-year, multicenter, prospective study indicate good survivorship for this novel, porous coated acetabular system. The overall survivorship of 97.14% at five-year follow-up is comparable to that reported for similar acetabular components and aligns with previous analyses (Teoh et al. 2018).

Background

A stem sitting proud (SP) or that above the final rasp position remains in some patients who undergo hip replacement using proximally coated tapered wedge stems. Surgeons may face challenges providing the best fit due to unpredictable stem seating. Zimmer Inc. introduced a new rasp to solve this issue but the clinical results of this rasp have not yet been published. Therefore, we aimed to address the following: 1) What is SP incidence using a proximally coated cementless tapered wedge stem? 2) Does the new rasp system improve seating height? 3) What are the risk factors of SP?

We maintain a database on 1000 femoral revisions using extensively porous-coated stems. Using femoral rerevision for any reason as an endpoint, the survivorship is 99 ± 0.8% (95% confidence interval) at 2 years, 97 ± 1.3% at 5 years, 95.6 ± 1.8% at 10 years, and 94.5 ± 2.2% at 15 years. Similar to Moreland and Paprosky, we have identified prerevision bone stock as a factor affecting femoral fixation. When the cortical damage involved bone more than 10 cm below the lesser trochanter, the survivorship, using femoral rerevision for any reason or definite radiographic loosening as an endpoint, was reduced significantly, as compared with femoral revisions with less cortical damage.

In addition to patients with Paprosky type 3B and 4 femoral defects there are rare patients with femoral canals smaller than 13.5 mm or larger than 26 mm that are not well suited to this technique. Eight and 10 inch stems 13.5 mm or smaller should be used with caution if there is no proximal bone support for fear of breaking. Patients with canals larger than 18 mm may be better suited for a titanium tapered stem with flutes. While a monolithic stem is slightly more difficult for a surgeon to insert than a modular femoral stem there is little worry about taper junction failure.

Clinical and radiological results of total hip arthroplasty (THA) using proximally coated single wedge (PSW) cementless stems are generally excellent. The geometry of cementless stems and the morphology of proximal femurs (Dorr types) provide optimal fit for primary stability and secondary biologic fixation. Because the geometry of PSW shape is designed to be engaged at the metaphysis, cementless PSW stem is not traditionally recommended to Dorr type C femurs with concerns of inadequate implant-host bone contact and the risk of femoral fracture. Nevertheless, previous studies on PSW cementless stems have not examined long-term survivorship according to Dorr types of femur. Paucity of a long-term comparative study makes it difficult to know whether the PSW stem plays a role in Dorr type C femurs or not. We postulated that the PSW stem could achieve stable fixation without increased risk of femoral fracture even in Dorr type C femurs, and demonstrate acceptable long-term results. The aim of this study was to investigate differences of clinical and radiological outcomes of THA using PSW stem according to proximal femoral geometry (Dorr types) in more than a 10-year follow-up.

Three hundred and seven primary THA in 247 patients, which was performed with use of a single-designed PSW stem from 1997 to 2003 and was followed up for over 10 years, were included in this retrospective study. According to Dorr's criteria, 89 femora were classified as Type A, 156 as Type B, and 62 as Type C. The patients' mean age at operation was 43.2 years (range, 18.4 – 69.6 years). They were followed-up for an average of 13.2 years (the range, 10.0 – 17.3 years). All of the hips were evaluated clinically and radiologically with special attention to the occurrence of implant loosening and periprosthetic femoral fracture.

The mean preoperative Harris hip score (50.4±20.6 points) improved significantly to 95.6±9.0 points at the final follow-ups. The improvements were observed regardless of Dorr types (p<0.001 in all 3 groups). The incidence of thigh pain (p=0.704) was not significantly different among groups. Implant survivorship was 100% in all 3 groups. None of the stems were loosened or revised. No significant differences were observed in osteolysis (p=0.492), pedestal formation (p=0.323), or cortical hypertrophy (p=0.169) among the groups [Fig. 1]. Radiolucent lines less than 2mm in thickness in Gruen zone 4 were observed more in Dorr type C femora than in Dorr type A or B (p=0.003) [Fig. 2]. Spot weld (p<0.001) and stress shielding (p=0.010) of proximal femur were more pronounced in Dorr C type femora than in type A or B [Fig. 3]. The prevalence of intraoperative (p=0.550) or postoperative (p=0.600) femoral fractures were not significantly different among the groups.

From over a 10-year follow-up, the PSW stem provided excellent stem survivorship regardless of Dorr type with satisfactory outcomes. The remodeling process around the stem was more pronounced in Dorr type C femur. The present study shows that the PSW stem is a recommendable option for Dorr type C femur.

For any figures or tables, please contact authors directly (see Info & Metrics tab above).

Introduction

Acetabular fixation is one of the major factors affecting long-term longevity and durability of total hip arthroplasty (THA). Limited data exist regarding mid-term performance of modern non-cemented rim-fit cups with HA coating. The aim of this study was to assess the minimum 5 year clinical and radiographic performance of PSL cups. Therefore we retrospectively analyzed results of this component in patients that had adequate followup from a prospective institutional database.